JP2004508045A5 - - Google Patents

Download PDF

Info

Publication number
JP2004508045A5
JP2004508045A5 JP2002525776A JP2002525776A JP2004508045A5 JP 2004508045 A5 JP2004508045 A5 JP 2004508045A5 JP 2002525776 A JP2002525776 A JP 2002525776A JP 2002525776 A JP2002525776 A JP 2002525776A JP 2004508045 A5 JP2004508045 A5 JP 2004508045A5
Authority
JP
Japan
Prior art keywords
peptide
phage
seq
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002525776A
Other languages
English (en)
Japanese (ja)
Other versions
JP5077862B2 (ja
JP2004508045A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/027692 external-priority patent/WO2002020769A1/en
Publication of JP2004508045A publication Critical patent/JP2004508045A/ja
Publication of JP2004508045A5 publication Critical patent/JP2004508045A5/ja
Application granted granted Critical
Publication of JP5077862B2 publication Critical patent/JP5077862B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002525776A 2000-09-08 2001-09-07 ファージディスプレイにより同定されたヒト及びマウスのターゲティングペプチド Expired - Fee Related JP5077862B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23126600P 2000-09-08 2000-09-08
US60/231,266 2000-09-08
US9765101A 2001-01-17 2001-01-17
US09/765,101 2001-01-17
PCT/US2001/027692 WO2002020769A1 (en) 2000-09-08 2001-09-07 Human and mouse targeting peptides identified by phage display

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2010277247A Division JP2011120587A (ja) 2000-09-08 2010-12-13 ファージディスプレイにより同定されたヒト及びマウスのターゲティングペプチド
JP2011245272A Division JP5591209B2 (ja) 2000-09-08 2011-11-09 ファージディスプレイにより同定されたヒト及びマウスのターゲティングペプチド

Publications (3)

Publication Number Publication Date
JP2004508045A JP2004508045A (ja) 2004-03-18
JP2004508045A5 true JP2004508045A5 (zh) 2012-01-05
JP5077862B2 JP5077862B2 (ja) 2012-11-21

Family

ID=26793502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002525776A Expired - Fee Related JP5077862B2 (ja) 2000-09-08 2001-09-07 ファージディスプレイにより同定されたヒト及びマウスのターゲティングペプチド

Country Status (3)

Country Link
JP (1) JP5077862B2 (zh)
AU (7) AU2001290652A1 (zh)
WO (1) WO2002020769A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022991A2 (en) * 2001-09-07 2003-03-20 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7671010B2 (en) 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US8507445B2 (en) 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
AU2002364501A1 (en) * 2002-08-30 2004-03-19 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
GB2429012A (en) * 2005-08-12 2007-02-14 Cartela Ab Polypeptides capable of binding an integrin I-domain.
HUE038787T2 (hu) 2011-02-11 2018-11-28 Univ Michigan Regents Tripeptid készítmények és alkalmazásuk diabétesz kezelésére
EP2537858A1 (en) * 2011-06-20 2012-12-26 Commissariat à l'Énergie Atomique et aux Énergies Alternatives Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine
EP2769983A1 (en) 2013-02-22 2014-08-27 Karlsruher Institut für Technologie Peptidomimetics possessing photo-controlled biological activity
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2421271A1 (en) * 2000-09-08 2002-03-14 Board Of Regents, The University Of Texas System Human and mouse targeting peptides identified by phage display

Similar Documents

Publication Publication Date Title
JP5591209B2 (ja) ファージディスプレイにより同定されたヒト及びマウスのターゲティングペプチド
US8710017B2 (en) Human and mouse targeting peptides identified by phage display
US8846859B2 (en) Compositions and methods of use of targeting peptides against placenta and adipose tissues
AU2007216854B2 (en) Human and mouse targeting peptides identified by phage display
US7914780B1 (en) Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20080003200A1 (en) GRP78 targeting peptides and methods employing same
JP2004508045A5 (zh)
US20130296252A1 (en) Muc18 targeting peptides
WO2003022991A2 (en) Compositions and methods of use of targeting peptides against placenta and adipose tissues
US20140356285A1 (en) Compositions and methods related to tissue targeting
CA2730627C (en) Human and mouse targeting peptides identified by phage display
Class et al. Patent application title: COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES AGAINST PLACENTA AND ADIPOSE TISSUES Inventors: Renata Pasqualini (Houston, TX, US) Renata Pasqualini (Houston, TX, US) Wadih Arap (Houston, TX, US) Mikhail G. Kolonin (Houston, TX, US) Mikhail G. Kolonin (Houston, TX, US)
Class et al. Patent application title: HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY Inventors: Wadih Arap (Houston, TX, US) Renata Pasqualini (Houston, TX, US) Renata Pasqualini (Houston, TX, US) Assignees: Board of Regents, The University of Texas System
WO2013043864A1 (en) Compositions and methods related to endothelial targeting